Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-078815

Chief Financial Officer sold 28,088 shares at an average $96.29 ($2,704,624)

  • Chief Financial Officer acquired 28,088 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Smith Hunter C Chief Financial Officer 2025-08-12 Option exercise 10b5-1 +24,611 $6.88 $169,324 141,526 D: show line 1 in the form
Smith Hunter C Chief Financial Officer 2025-08-12 Sale 10b5-1 −24,611 $96.33 $2,370,832 116,915 D: show line 2 in the form
Smith Hunter C Chief Financial Officer 2025-08-13 Option exercise 10b5-1 +3,477 $6.88 $23,922 120,392 D: show line 3 in the form
Smith Hunter C Chief Financial Officer 2025-08-13 Sale 10b5-1 −3,477 $96.00 $333,792 116,915 D: show line 4 in the form
Open-market sales · 28,088 sh · avg $96.29 · $2,704,624

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Smith Hunter C Chief Financial Officer 2025-08-12 Option exercise · Stock Options (Right to Buy) 10b5-1 −24,611 3,477 D: show line 5 in the form
Smith Hunter C Chief Financial Officer 2025-08-13 Option exercise · Stock Options (Right to Buy) 10b5-1 −3,477 0 D: show line 6 in the form
Loading xslF345X05/tm2523328-3_4seq1.xml…